Milestone Pharmaceuticals, Inc. (MIST)
0.6482
-0.05
(-7.76%)
USD |
NASDAQ |
Oct 23, 16:00
0.65
0.00 (0.00%)
After-Hours: 20:00
Milestone Pharmaceuticals Total Return Level : 0.6482 for Oct. 23, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.6482 |
| October 22, 2026 | 0.7027 |
| October 21, 2026 | 0.6953 |
| October 20, 2026 | 0.7185 |
| October 19, 2026 | 0.7001 |
| October 16, 2026 | 0.7073 |
| October 15, 2026 | 0.7945 |
| October 14, 2026 | 0.7879 |
| October 13, 2026 | 0.7658 |
| October 12, 2026 | 0.8055 |
| October 09, 2026 | 0.765 |
| October 08, 2026 | 0.7121 |
| October 07, 2026 | 0.7572 |
| October 06, 2026 | 0.7642 |
| October 05, 2026 | 0.7794 |
| October 02, 2026 | 0.8097 |
| October 01, 2026 | 0.8157 |
| September 30, 2026 | 0.8657 |
| September 29, 2026 | 0.82 |
| September 28, 2026 | 0.7954 |
| September 25, 2026 | 0.7884 |
| September 24, 2026 | 0.7949 |
| September 23, 2026 | 0.862 |
| September 22, 2026 | 0.921 |
| September 21, 2026 | 0.9178 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.9158 |
| September 17, 2026 | 0.9196 |
| September 16, 2026 | 0.8892 |
| September 15, 2026 | 0.9277 |
| September 14, 2026 | 0.9494 |
| September 11, 2026 | 0.9801 |
| September 10, 2026 | 1.05 |
| September 09, 2026 | 1.07 |
| September 08, 2026 | 1.125 |
| September 04, 2026 | 1.20 |
| September 03, 2026 | 1.21 |
| September 02, 2026 | 1.18 |
| September 01, 2026 | 1.14 |
| August 31, 2026 | 1.16 |
| August 28, 2026 | 1.16 |
| August 27, 2026 | 1.19 |
| August 26, 2026 | 1.18 |
| August 25, 2026 | 1.16 |
| August 24, 2026 | 1.04 |
| August 21, 2026 | 1.055 |
| August 20, 2026 | 1.03 |
| August 19, 2026 | 1.08 |
| August 18, 2026 | 1.07 |
| August 17, 2026 | 1.10 |
| August 14, 2026 | 1.10 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| InMed Pharmaceuticals, Inc. | 1.44 |
| NervGen Pharma Corp. | 1.43 |
| Appili Therapeutics, Inc. | 0.0068 |
| Clearmind Medicine, Inc. | 5.87 |
| Lexaria Bioscience Corp. | 3.08 |